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Anaphylaxis is an acute, life-threatening, systemic reac-
tion with varied clinical presentations and severity that
results from the systemic release of mediators from
mast cells and basophils. The diagnosis of food-induced
anaphylaxis is based on a combination of medical his-
tory and presence of specific IgE to the responsible
food. In general, the more rapid the onset of symptoms
following exposure to the allergen, the more likely the
reaction will be severe and life threatening. However
when ingested food is the allergen, it may take up to 25
minutes from onset of anaphylaxis to cardiopulmonary
arrest, making the diagnosis even more challenging. In
food-induced, fatal anaphylaxis episodes up to 80% are
not associated with cutaneous signs or symptoms, the
signal that most patients will recognize first. Further-
more, it is well established that patients with food-
induced anaphylaxis under utilize epinephrine. Thus,
ongoing education for the patient who is at risk for ana-
phylaxis becomes essential.
While occurrences of food allergy are believed to be
increasing, the true prevalence is unknown. Food aller-
gies are highest in children and adolescents and are
thought to be the most common cause of anaphylaxis in
the outpatient setting, accounting for approximately 30%
of fatal reactions. Fatalities from food-induced anaphy-
laxis are highest in teenagers and young adults, among
those with asthma, and in cases when there has been a
delay in the administration of epinephrine. Biphasic
reactions occur in approximately 25% of fatal and near-
fatal, food-induced anaphylaxis events. Special circum-
stances involving food allergy that will be discussed
include exercise-induced anaphylaxis, unsuspecting hid-
den food allergy, and the significance of food allergy for
vaccine administration.
The treatment of anaphylaxis involves the immediately
administration of epinephrine. When there is any doubt
about the diagnosis, it is generally best to administer
epinephrine rather than waiting for more severe symp-
toms. In the treatment of food-induced anaphylaxis,
more than a single dose of epinephrine may be required;
these doses can be given every 5-10 minutes, and a
longer period of observation is recommended. While IM
administration is preferred by many national and inter-
national guidelines, the controversy over IM vs. subcuta-
neous epinephrine use will be discussed. Following the
administration of epinephrine, other treatment modal-
ities include 1) placing the patient in a supine position,
2) oxygen, and 3) fluid replacement. The role of the sec-
ond line, supportive medications including H1 and H2
antihistamines and corticosteroids has not been estab-
lished for the treatment of acute, biphasic, or prolonged
anaphylaxis. Glucagon may be considered in patients
taking a beta-blocker who are not responding to
epinephrine.
Physicians and office staff need to maintain clinical
proficiency in anaphylaxis management, which should
include an established written plan to deal with anaphy-
laxis and regular practice sessions. An action plan for
the diagnosis and management of food-induced anaphy-
laxis should be provided to every patient with food aller-
gies. A review of the action plan and technique for auto-
injection of epinephrine should occur at regularly sched-
uled office visits. Recognizing that at the present time,
there is no way to prevent food-induced anaphylaxis
other than by avoiding the food. the patient requires fre-
quent reinforcement that epinephrine, NOT antihista-
mines, is the only effective medication for the treatment
of anaphylaxis and that a delay in administration is asso-
ciated with more severe symptoms and a higher rate of
fatality. Every patient with food-induced anaphylaxis
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